Please use the [BTAS website https://rconnect.dfci.harvard.edu/BTAS/](https://rconnect.dfci.harvard.edu/BTAS/) to access  machine learning and deep learning models, which  estimate tumor activity of bipotent target that are predictive of immunotherapy response for melanoma patients.  
